|
|
222 Third Street
Suite 0123
Cambridge
MA
2142
United States
866-436-3339
|
|
Private
|
Hemedex, Inc. was founded in 2000 to commercialize a proprietary platform technology conceived at the Massachusetts Institute of Technology (M.I.T.), for the purpose of measuring tissue perfusion (i.e., blood flow at the capillary level). This technology addresses high clinical need situations in complex medical and surgical procedures. These complex procedures often involve compromised vasculature and other serious pathophysiology, which results in high rates of morbidity, delayed recuperation, poor patient outcome and higher overall costs. The Company's patented technology provides clinicians with a powerful tool to generate valuable prognostic data, which can provide an early warning of impending tissue ischemia and help target appropriate therapies rapidly and accurately.
|
|
http://www.hemedex.com/
|
|
|
|
|
|
|
|
|
|
|
|